14 February 2023
External Circular: Enhancing Procedures for Notification and investigation of the National Measles, Rubella and Congenital Rubella Syndrome (CRS) Elimination Program
Reference: CIR-2023-00000017
To: All Health Professionals & Health Facilities within the jurisdiction of Dubai Heath Authority –Dubai
|
Greetings from Health Regulation Sector- DHA.
kindly find the attached circular # 0230 on:
Enhancing Procedures for Notification and investigation of the National Measles, Rubella and Congenital Rubella Syndrome (CRS) Elimination Program
For your kind compliance and adherence as per the contained instructions.
Supporting Documents:
- Circular # 0230,
- DM-SRV-LAB-22-909 RLID Measles Guidelines,
- National Program for Measles and Rubella Elimination Lab Request Form,
- Annex 1_Case definitions and classification,
- Annex 2_Reference Laboratory Investigation form National Program for Measles and Rubella Elimination Lab Request Form,
- Annex 3_Measles Laboratory Guidelines Specimen Collection and Shipment_DM-SRV-LAB-22-909 RLID Measles Guidelines.
Best regards.
Supporting Documents:
تعزيز اجراءات التبليغ والتحقق وفق البرنامج الوطني للقضاء على الحصبة والحصبة الألمانية ومتلازمة الحصبة الألمانية الخلقية (CRS)14.02.2023).pdf:
View Document
DM-SRV-LAB-22-909 RLID Measles Guidelines.pdf:
View Document
National Program for Measles and Rubella Elimination Lab Request Form.pdf:
View Document
Annex 1_Case definitions and classification.pdf:
View Document
Annex 2_Reference Laboratory Investigation form_National Program for Measles and Rubella Elimination Lab Request Form.pdf:
View Document
Annex 3_Measles Laboratory Guidelines Specimen Collection and Shipment_DM-SRV-LAB-22-909 RLID Measles Guidelines.pdf:
View Document